Instrument dashboard

Elevance Health, Inc. (ELV)

NYSE · US

ELV · Market chart

Loading chart…

Latest Pine script: 2026-11-18

Market structure

PRICE LEVEL INTELLIGENCE

Reference close · 2026-11-20
LEVEL / SOURCEPRICE LEVELPRICE
Double Bottom 1TECHNICAL · Primary structural anchor from 2025-08-06 low of 273.71 to 2026-01-15 high of 383.00. x is elapsed calendar days since 2025-08-06 00:00 UTC. This is the rising first leg of the primary double-bottom structure.
—
Double Bottom 2TECHNICAL · Primary structural anchor from the 2026-01-15 high of 383.00 to the 2026-03-09 low of 274.84. x is elapsed calendar days since 2026-01-15 00:00 UTC. This is the descending middle leg connecting the neckline to the second major trough.
—
Double Bottom 2TECHNICAL · Primary structural anchor from the 2026-03-09 low of 274.84 to the 2026-06-10 high of 426.98. x is elapsed calendar days since 2026-03-09 00:00 UTC. This is the rising recovery and breakout leg of the primary structure.
—
Rising SupportTECHNICAL · Secondary rising structural support anchored at the 2026-03-09 low of 274.84 and the 2026-10-01 low of 375.74. x is elapsed calendar days since 2026-03-09 00:00 UTC. The trajectory connects two independently observed historical lows and represents the lower rising structural boundary.
—
Rising Upper BoundaryTECHNICAL · Secondary rising structural boundary anchored at the 2026-06-10 high of 426.98 and the 2026-10-21 high of 450.69. x is elapsed calendar days since 2026-06-10 00:00 UTC. The trajectory connects two historical swing highs and represents the upper rising boundary.
—
ATR Support 401.64–426.98TECHNICAL · Boundaries derive from the 2026-06-10 significant control bar, whose true range was 25.34 against Wilder ATR(14) of approximately 11.48, exceeding twice ATR. The boundaries are the control bar low and high. The region intersects the May 2026 monthly R1 of 411.81 and the primary structural breakout high of 426.98. Current close is above the region, making it support.
401.64 – 426.98
ATR Support 406.00–421.90TECHNICAL · Boundaries derive from the 2026-09-10 significant control bar, whose true range was 25.00 against Wilder ATR(14) of approximately 11.27, exceeding twice ATR. The boundaries are the control bar low and high. The region intersects the August 2026 monthly R1 of 411.73 and May 2026 monthly R1 of 411.81. Current close is above the region, making it support.
406.00 – 421.90
ATR Resistance 536.07–555.36TECHNICAL · Boundaries derive from the 2024-07-16 significant control bar, whose true range was 24.70 against Wilder ATR(14) of approximately 10.63, exceeding twice ATR. The boundaries are the control bar low and high. The region intersects the June 2024 monthly pivot of 537.88 and first resistance pivot of 553.97. Current close is below the region, making it resistance.
536.07 – 555.36
ATR Resistance 536.33–562.12TECHNICAL · Boundaries derive from the 2024-09-04 significant control bar, whose true range was 25.96 against Wilder ATR(14) of approximately 10.12, exceeding twice ATR. The boundaries are the control bar low and high. The region intersects the August 2024 monthly pivot of 543.83. Current close is below the region, making it resistance.
536.33 – 562.12
October S1 380.31TECHNICAL · Traditional monthly first support pivot calculated from October 2026 high of 450.69, low of 375.74, and close of 420.07. Calculated as 2P - H. It is support when close >= 380.31 and resistance otherwise.
380.31
Double Bottom NecklineTECHNICAL · Horizontal resistance reference established by the 2026-01-15 swing high of 383.00 between the two major lows. It is support when close >= 383.00 and resistance otherwise.
383.00
Analyst 12-month low targetANALYST · Lowest analyst 12-month price target
406.00
August 2026 R1 411.73TECHNICAL · Traditional monthly first resistance pivot calculated from July 2026 high of 436.24, low of 362.98, and close of 374.86. Calculated as 2P - L. It is support when close >= 411.73 and resistance otherwise.
411.73
May 2026 R1 411.81TECHNICAL · Traditional monthly first resistance pivot calculated from May 2026 high of 408.00, low of 366.95, and close of 393.19. Calculated as 2P - L. It is support when close >= 411.81 and resistance otherwise.
411.81
October Pivot 415.50TECHNICAL · Traditional monthly pivot calculated from October 2026 high of 450.69, low of 375.74, and close of 420.07. Calculated as (H + L + C) / 3. It is support when close >= 415.50 and resistance otherwise.
415.50
October R1 455.26TECHNICAL · Traditional monthly first resistance pivot calculated from October 2026 high of 450.69, low of 375.74, and close of 420.07. Calculated as 2P - L. It is support when close >= 455.26 and resistance otherwise.
455.26
Analyst 12-month median targetANALYST · Median analyst 12-month price target
492.00
Analyst 12-month high targetANALYST · Highest analyst 12-month price target
523.00
July 2024 P 537.88TECHNICAL · Traditional monthly pivot calculated from June 2024 high of 549.99, low of 521.78, and close of 541.86. Calculated as (H + L + C) / 3. It is support when close >= 537.88 and resistance otherwise.
537.88
August 2024 P 543.83TECHNICAL · Traditional monthly pivot calculated from August 2024 high of 557.60, low of 517.01, and close of 556.89. Calculated as (H + L + C) / 3. It is support when close >= 543.83 and resistance otherwise.
543.83
July 2024 R1 553.97TECHNICAL · Traditional monthly first resistance pivot calculated from June 2024 high of 549.99, low of 521.78, and close of 541.86. Calculated as 2P - L. It is support when close >= 553.97 and resistance otherwise.
553.97
GEX put wall · 2026-12-18GEX · Options positioning
410.00
GEX call wall · 2026-12-18GEX · Options positioning
440.00

Sign in to view price levels

Technical, analyst and options-derived levels are available to signed-in members.

Sign in
AI-Ready Research Pack

Download the available financial metrics, calculation methodology and latest technical price levels for ELV.

Download research pack
Files included for this instrument:
  • SEC financial metrics calculation guide
  • Financial metrics for the current year
  • Technicals and future GEX levels
Company fundamentals

Financial health

Revenue••••••Profitability••••••Cash flow••••••Capital structure••••••
Available reporting years2026, 2025

Sign in to request beta access

Financial health insights are in a limited beta.

Sign in
Valuation framework

Valuation

Midpoint fair value••••••
Cash Flow DCF••••••
Revenue unit economics••••••
Reporting periods: 3 quarters available

Sign in to request beta access

Valuation tools are in a limited beta.

Sign in